BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35789314)

  • 1. Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
    Fraz MSA; Michelsen AE; Moe N; Aaløkken TM; Macpherson ME; Nordøy I; Aukrust P; Taraldsrud E; Holm AM; Ueland T; Jørgensen SF; Fevang B
    J Clin Immunol; 2022 Oct; 42(7):1553-1563. PubMed ID: 35789314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
    Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
    J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
    Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
    Front Immunol; 2021; 12():627423. PubMed ID: 33777011
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease.
    Lui VG; Ghosh T; Rymaszewski A; Chen S; Baxter RM; Kong DS; Ghosh D; Routes JM; Verbsky JW; Hsieh EWY
    J Clin Immunol; 2023 Aug; 43(6):1311-1325. PubMed ID: 37093407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulomatous lymphocytic interstitial lung disease (GLILD) as a manifestation of pulmonary changes in common variable immunodeficiency (CVID) – case report].
    Marciszewska E; Szaflarska A; Pituch-Noworolska A
    Przegl Lek; 2016; 73(7):530-3. PubMed ID: 29677427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
    Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
    Front Immunol; 2020; 11():617985. PubMed ID: 33584710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.
    Mannina A; Chung JH; Swigris JJ; Solomon JJ; Huie TJ; Yunt ZX; Truong TQ; Brown KK; Achcar RD; Olson AL; Cox CW; Kligerman SJ; Curran-Everett D; Fernández Pérez ER
    Ann Am Thorac Soc; 2016 Jul; 13(7):1042-9. PubMed ID: 27064856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
    Park JH; Levinson AI
    Clin Immunol; 2010 Feb; 134(2):97-103. PubMed ID: 19900842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulomatous lymphocytic interstitial lung disease: description of a series of 9 cases.
    Ruiz-Alcaraz S; Gayá García-Manso I; Marco-De La Calle FM; García-Mullor MDM; López-Brull H; García-Sevila R
    Med Clin (Barc); 2021 Apr; 156(7):344-348. PubMed ID: 33478812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
    Chase NM; Verbsky JW; Hintermeyer MK; Waukau JK; Tomita-Mitchell A; Casper JT; Singh S; Shahir KS; Tisol WB; Nugent ML; Rao RN; Mackinnon AC; Goodman LR; Simpson PM; Routes JM
    J Clin Immunol; 2013 Jan; 33(1):30-9. PubMed ID: 22930256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
    Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
    BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.
    Lamers OAC; Smits BM; Leavis HL; de Bree GJ; Cunningham-Rundles C; Dalm VASH; Ho HE; Hurst JR; IJspeert H; Prevaes SMPJ; Robinson A; van Stigt AC; Terheggen-Lagro S; van de Ven AAJM; Warnatz K; van de Wijgert JHHM; van Montfrans J
    Front Immunol; 2021; 12():606099. PubMed ID: 33936030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency.
    Hartono S; Motosue MS; Khan S; Rodriguez V; Iyer VN; Divekar R; Joshi AY
    Ann Allergy Asthma Immunol; 2017 May; 118(5):614-620. PubMed ID: 28254202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.
    van de Ven AAJM; Alfaro TM; Robinson A; Baumann U; Bergeron A; Burns SO; Condliffe AM; Fevang B; Gennery AR; Haerynck F; Jacob J; Jolles S; Malphettes M; Meignin V; Milota T; van Montfrans J; Prasse A; Quinti I; Renzoni E; Stolz D; Warnatz K; Hurst JR
    Front Immunol; 2020; 11():606333. PubMed ID: 33324422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomatous Lymphocytic Interstitial Lung Disease in a Spectrum of Pediatric Primary Immunodeficiencies.
    Szczawinska-Poplonyk A; Jonczyk-Potoczna K; Mikos M; Ossowska L; Langfort R
    Pediatr Dev Pathol; 2021; 24(6):504-512. PubMed ID: 34176349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
    Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
    J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 18-year-old woman with Kabuki syndrome, immunoglobulin deficiency and granulomatous lymphocytic interstitial lung disease.
    De Dios JA; Javaid AA; Ballesteros E; Metersky ML
    Conn Med; 2012 Jan; 76(1):15-8. PubMed ID: 22372173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency.
    Bates CA; Ellison MC; Lynch DA; Cool CD; Brown KK; Routes JM
    J Allergy Clin Immunol; 2004 Aug; 114(2):415-21. PubMed ID: 15316526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
    Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
    Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
    Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
    Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.